Heparin inhibits osteoclastic differentiation and function, Journal of Cellular Biochemistry, vol.24, issue.6, pp.1707-1717, 2008. ,
DOI : 10.1002/jcb.21559
Mechanisms Involved in Enhancement of Osteoclast Formation and Function by Low Molecular Weight Hyaluronic Acid, Journal of Biological Chemistry, vol.280, issue.19, pp.18967-18972, 2005. ,
DOI : 10.1074/jbc.M412740200
A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry, American Journal of Obstetrics and Gynecology, vol.170, issue.3, pp.862-869, 1994. ,
DOI : 10.1016/S0002-9378(94)70299-3
RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases, Cell. Mol. Life Sci, vol.64, pp.2334-2350, 2007. ,
Functions of Cell Surface Heparan Sulfate Proteoglycans, Annual Review of Biochemistry, vol.68, issue.1, pp.729-777, 1999. ,
DOI : 10.1146/annurev.biochem.68.1.729
Characterization of MCSF-induced proliferation and subsequent osteoclast formation in murine marrow culture, Journal of Bone and Mineral Research, vol.134, issue.7, pp.1025-1032, 1995. ,
DOI : 10.1002/jbmr.5650100706
Osteoclast differentiation and activation, Nature, vol.34, issue.6937, pp.337-342, 2003. ,
DOI : 10.1007/s007740200049
Molecular regulation of osteoclast activity, Reviews in Endocrine and Metabolic Disorders, vol.4, issue.6, pp.123-139, 2006. ,
DOI : 10.1007/s11154-006-9009-x
Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4, Journal of Cell Science, vol.120, issue.1, pp.166-176, 2007. ,
DOI : 10.1242/jcs.03310
URL : http://jcs.biologists.org/cgi/content/short/jcs.03310v1
Disease Status in Autosomal Dominant Osteopetrosis Type 2 Is Determined by Osteoclastic Properties, Journal of Bone and Mineral Research, vol.19, issue.S2, pp.1089-1097, 2006. ,
DOI : 10.1359/jbmr.060409
Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers-Danlos-Like Changes in Bone and Other Connective Tissues, Journal of Bone and Mineral Research, vol.87, issue.Suppl V, pp.1180-1189, 2002. ,
DOI : 10.1359/jbmr.2002.17.7.1180
Phosphorylation of Signal Transducer and Activator of Transcription 3, Endocrinology, vol.149, issue.7, pp.3688-3697, 2008. ,
DOI : 10.1210/en.2007-1719
URL : https://hal.archives-ouvertes.fr/inserm-00667501
OSTEOPETROTIC MOUSE, Endocrinology, vol.127, issue.5, pp.2592-2594, 1990. ,
DOI : 10.1210/endo-127-5-2592
Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro, Pharmacol. Rep, vol.57, pp.635-645, 2005. ,
Heparin augments osteoclast resorption-stimulating activity in serum, Journal of Cellular Physiology, vol.52, issue.2, pp.208-214, 1991. ,
DOI : 10.1002/jcp.1041470204
Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents, Endocrinology, vol.147, issue.4, 1979. ,
DOI : 10.1210/en.2005-1340
Multiprotein signalling complexes: regional assembly on heparan sulphate, Biochemical Society Transactions, vol.34, issue.3, pp.34438-34479, 2006. ,
DOI : 10.1042/BST0340438
Glycosaminoglycan Sulfation Requirements for Respiratory Syncytial Virus Infection, Journal of Virology, vol.74, issue.22, pp.10508-10513, 2000. ,
DOI : 10.1128/JVI.74.22.10508-10513.2000
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC110925
Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity, Bone, vol.41, issue.2, pp.165-174, 2007. ,
DOI : 10.1016/j.bone.2007.04.190
Proteoglycans: key partners in bone cell biology, BioEssays, vol.53, issue.8, pp.758-771, 2007. ,
DOI : 10.1002/bies.20612
Glycosaminoglycans as Potential Regulators of Osteoprotegerin Therapeutic Activity in Osteosarcoma, Cancer Research, vol.69, issue.2, pp.526-536, 2009. ,
DOI : 10.1158/0008-5472.CAN-08-2648
Regulation of Collagenase Activities of Human Cathepsins by Glycosaminoglycans, Journal of Biological Chemistry, vol.279, issue.7, pp.5470-5479, 2004. ,
DOI : 10.1074/jbc.M310349200
Elucidation of the Structural Features of Heparan Sulfate Important for Interaction with the Hep-2 Domain of Fibronectin, Journal of Biological Chemistry, vol.275, issue.7, pp.4599-4606, 2000. ,
DOI : 10.1074/jbc.275.7.4599
Reduced Glycosaminoglycan Sulfation Diminishes the Agrin Signal Transduction Pathway, Developmental Neuroscience, vol.26, issue.1, pp.1-10, 2004. ,
DOI : 10.1159/000080706
Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.5, pp.2964-2971, 2005. ,
DOI : 10.1210/jc.2004-1895
Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo, Blood, vol.88, pp.1314-1320, 1996. ,
Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts, Arthritis & Rheumatism, vol.16, issue.8, pp.2450-2458, 2004. ,
DOI : 10.1002/art.20367
The effects of heparin and low molecular weight heparins on bone, Thrombosis Research, vol.122, issue.3, pp.293-298, 2008. ,
DOI : 10.1016/j.thromres.2006.10.025
Cooperative Dimerization of Fibroblast Growth Factor 1 (FGF1) upon a Single Heparin Saccharide May Drive the Formation of 2:2:1 FGF1{middle dot}FGFR2c{middle dot}Heparin Ternary Complexes, Journal of Biological Chemistry, vol.280, issue.51, pp.42274-42282, 2005. ,
DOI : 10.1074/jbc.M505720200
Osteoclastic acidification pathways during bone resorption, Bone, vol.30, issue.4, pp.533-540, 2002. ,
DOI : 10.1016/S8756-3282(02)00672-5
Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha, Journal of Experimental Medicine, vol.179, issue.4, pp.1109-1118, 1994. ,
DOI : 10.1084/jem.179.4.1109
Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density, Cell, vol.89, issue.2, pp.309-319, 1997. ,
DOI : 10.1016/S0092-8674(00)80209-3
Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells, Blood, vol.100, issue.8, pp.3002-3007, 2002. ,
DOI : 10.1182/blood-2002-04-1190
Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: Role in the interactions with receptor activator of nuclear factor ??B ligand (RANKL) and RANK, Biochemical and Biophysical Research Communications, vol.347, issue.2, pp.460-467, 2006. ,
DOI : 10.1016/j.bbrc.2006.06.120
Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse., Proceedings of the National Academy of Sciences, vol.87, issue.12, pp.4828-4832, 1990. ,
DOI : 10.1073/pnas.87.12.4828
Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities, Experimental Cell Research, vol.293, issue.2, pp.292-301, 2004. ,
DOI : 10.1016/j.yexcr.2003.10.016
Identity of Osteoclastogenesis Inhibitory Factor (OCIF) and Osteoprotegerin (OPG): A Mechanism by which OPG/OCIF Inhibits Osteoclastogenesis in Vitro, Endocrinology, vol.139, issue.3, pp.1329-1337, 2004. ,
DOI : 10.1210/en.139.3.1329